glp 1 is a peptide Schematic representation of different GLP-1 analogues previously Glucagon-like peptide-1: Trends in Endocrinology

Pricing is flat per compound monthlyyour dose may need to go up, but your price won't

The dual-receptor approach may allow for more comprehensive modeling of metabolic corrections than GLP-1 agonism alone

But it can also lead to gastrointestinal issues

Scientific Reports

Some patients might feel a slight headache or fatigue

In summary, while a meta-analysis of these trials could yield valuable insights into the class effect of GLP-1 receptor agonists on OSA severity in populations with obesity (with or without T2DM), caution must be exercised in interpreting pooled results due to heterogeneity in population, intervention, and background therapy